Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NN-220 in Adults With Growth Hormone Deficiency
NCT00519558Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- May 2003
- Primary completion
- Jan 2005
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of somatropin in growth hormone deficiency (GHD), sponsored by Novo Nordisk. Started May 2003; status: completed.
02
Drugs
somatropin
03
Conditions
growth hormone deficiency (GHD)
Beyond the preview
Go deeper on NCT00519558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00519558.